Àvida Biotech

Start Up Exhibitor

Àvida Biotech is developing broad-spectrum antiviral products to prevent neglected and emerging infectious diseases. These products will be oral and thermostable, which reduces their overall cost and will make them widely affordable to achieve maximal impact. Our main focus is on dengue, chikungunya and zika. We have proof of concept of oral vaccination in a mouse model of dengue.





Sign Up for Event Updates